Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States

Published:2018-01-13 Issue:3 Volume:168 Page:727-737
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Poorvu Philip D.,Vaz-Luis Ines,Freedman Rachel A.,Lin Nancy U.,Barry William T.,Winer Eric P.,Hassett Michael J.

Funder

Fundação para a Ciência e a Tecnologia

Dana-Farber Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4659-4/fulltext.html

Reference66 articles.

1. DeSantis CE, Lin CC, Mariotto AB et al (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252–271

2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

3. Miller KD, Sledge GW (1999) The role of chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am 13(2):415–434

4. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

5. Chia SK, Speers CH, D’Yachkova Y et al (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110(5):973–979

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study;npj Breast Cancer;2024-07-17

2. Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort;Clinical and Translational Oncology;2024-03-22

3. Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?;Annals of Surgical Oncology;2023-03-25

4. Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2– metastatic breast cancer in the United States;Breast Cancer Research and Treatment;2023-01-07

5. Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects;Clinical Interventions in Aging;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3